UCL Stroke Research (@uclstrokeres) 's Twitter Profile
UCL Stroke Research

@uclstrokeres

UCL Stroke Research Centre does cutting-edge stroke research and clinical trials at UCL Institute of Neurology and the National Hospital, Queen Square

ID: 831471329295609856

calendar_today14-02-2017 11:53:07

1,1K Tweet

2,2K Followers

739 Following

JAHA (@jaha_aha) 's Twitter Profile Photo

Novel study ties lower CSF Aβ42 to CAA severity through CAA-related macrohemorrhages and enlarged perivascular spaces, advancing biomarker-driven approaches. #AHAJournals Baris Alten, MD, PhD Mariel Kozberg Edip Gurol Steven M. Greenberg MD, PhD MGH Neurology Brigham and Women's Neurology ahajrnls.org/4hpRlBN

Novel study ties lower CSF Aβ42 to CAA severity through CAA-related macrohemorrhages and enlarged perivascular spaces, advancing biomarker-driven approaches. #AHAJournals <a href="/AltenBaris/">Baris Alten, MD, PhD</a> <a href="/MarielKozberg/">Mariel Kozberg</a> <a href="/guroledip/">Edip Gurol</a> <a href="/SMGreenbergNeur/">Steven M. Greenberg MD, PhD</a> <a href="/MGHNeurology/">MGH Neurology</a> <a href="/BWHNeurology/">Brigham and Women's Neurology</a> ahajrnls.org/4hpRlBN
European Stroke Org (@esostroke) 's Twitter Profile Photo

🚨EXCOA-CVT trial at #ESOC2025:Extending oral anticoagulation after cerebral vein thrombosis shows no clear benefit vs. short-term use. Both VTE recurrence & bleeding rates low. Individualised treatment decisions are key! #Stroke #CVT #VoiceOfStroke #StrokeTwitter Diana Aguiar de Sousa

🚨EXCOA-CVT trial at #ESOC2025:Extending oral anticoagulation after cerebral vein thrombosis shows no clear benefit vs. short-term use. Both VTE recurrence &amp; bleeding rates low. Individualised treatment decisions are key! #Stroke #CVT #VoiceOfStroke #StrokeTwitter <a href="/Diana_A_Sousa/">Diana Aguiar de Sousa</a>
Seemant Chaturvedi (@chaturvedineuro) 's Twitter Profile Photo

Analysis from OPTIMAS trial shows that persistent AF associated with higher outcome event rate and mortality. No treatment effect seen with early DOAC use according to AF subtype #ESOC2025

Analysis from OPTIMAS trial shows that persistent AF associated with higher outcome event rate and mortality. No treatment effect seen with early DOAC use according to AF subtype #ESOC2025
European Stroke Org (@esostroke) 's Twitter Profile Photo

New 5-year data from the DEMDAS study presented at #ESOC2025: Metabolic syndrome is a strong, modifiable risk factor for dementia after stroke—especially delayed-onset cases. Time to rethink post-stroke care and prevention. #StrokeRecovery #SecondaryStrokePrevention #ESOC2025

New 5-year data from the DEMDAS study presented at #ESOC2025: Metabolic syndrome is a strong, modifiable risk factor for dementia after stroke—especially delayed-onset cases. Time to rethink post-stroke care and prevention. #StrokeRecovery #SecondaryStrokePrevention #ESOC2025
British & Irish Association of Stroke Physicians (@biaspstroke) 's Twitter Profile Photo

Want to enhance your ability to recognise an acute stroke & perform a thorough clinical assessment? Register to attend the UK & ROI Acute Stroke Simulation Courses 2025 👉 biasp.org/training-educa…

Want to enhance your ability to recognise an acute stroke &amp; perform a thorough clinical assessment?

Register to attend the UK &amp; ROI Acute Stroke Simulation Courses 2025 👉 biasp.org/training-educa…
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE Simultaneous publication at #ESOC2025 🔴🔵 #OPTIMAS trial finds that chronic kidney disease does not modify the effects of early versus delayed DOAC initiation after acute ischemic stroke. #AHAJournals ahajrnls.org/3SLFPXg

#STROKE Simultaneous publication at #ESOC2025 🔴🔵

#OPTIMAS trial finds that chronic kidney disease does not modify the effects of early versus delayed DOAC initiation after acute ischemic stroke. #AHAJournals

ahajrnls.org/3SLFPXg
Jan Scheitz 🧠⚡️❤️ (@jan_frisch) 's Twitter Profile Photo

Just published in The Lancet Neurology and presented at #ESOC2025 The DAYLIGHT RCT showing improved detection of cardiac thrombi without delay in IVT by extended CT angiography including the heart. Great effort by Luciano Sposato 🇦🇷🇨🇦 & Rodrigo Bagur 🇦🇷🇨🇦 and team 👏👏👏 sciencedirect.com/science/articl…

Just published in <a href="/TheLancetNeuro/">The Lancet Neurology</a> and presented at #ESOC2025 
The DAYLIGHT RCT showing improved detection of cardiac thrombi without delay in IVT by extended CT angiography including the heart. 
Great effort by <a href="/SposatoL/">Luciano Sposato 🇦🇷🇨🇦</a> &amp; <a href="/RodrigoBagur/">Rodrigo Bagur 🇦🇷🇨🇦</a> and team 
👏👏👏

sciencedirect.com/science/articl…
European Stroke Org (@esostroke) 's Twitter Profile Photo

🧠💉 Can blood thinners be safely used after a brain bleed? STATICH-2 trial: 134 patients with haemorrhagic stroke and strong need for blood thinners were enrolled to tackle this question. Results revealed today at #ESOC2025 – with potential to shape future stroke care. #Stroke

🧠💉 Can blood thinners be safely used after a brain bleed?
STATICH-2 trial: 134 patients with haemorrhagic stroke and strong need for blood thinners were enrolled to tackle this question. Results revealed today at #ESOC2025 – with potential to shape future stroke care.
#Stroke
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#ESOC2025 #STATICH Antithrombotic treatment after ICH 1ry outcome: recurrent symptomatic ICH at 2y FU Antiplatelets vs no: 3 vs 1 Anticoagulation vs no: 1 vs 1 ☝️Underpowered to make clinical conclusions (just 134 patients, very few events)

#ESOC2025

#STATICH Antithrombotic treatment after ICH

1ry outcome: recurrent symptomatic ICH at 2y FU

Antiplatelets vs no: 3 vs 1 
Anticoagulation vs no: 1 vs 1

☝️Underpowered to make clinical conclusions (just 134 patients, very few events)
Malik Ghannam (@ghannammalik) 's Twitter Profile Photo

Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial | Stroke ahajournals.org/doi/full/10.11…

Cambridge Stroke (@camstroke) 's Twitter Profile Photo

Are you a student, clinician or researcher interested in Stroke? Or just interested in lastest evidence?Registration and abstract submission open for UK Stroke Research Workshop 2025 Newcastle 3-4th Sept. Great speakers; incredible value! more here: strokeworkshop.uk

Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

The Rule of 26: In the SELECT-2 trial of EVT for large core LVO in which an overall benefit was seen, a large (>26 ml) core of severe hypodensity (<26 HU) negated the benefit of thrombectomy and was associated w/ an ⬆️ risk of hemicraniectomy ahajournals.org/doi/abs/10.116…

UK Stroke Forum (@ukstrokeforum) 's Twitter Profile Photo

Looking for something to do on bank holiday Monday? 🤔 You could complete that abstract for #UKSF25 which you were so upset you missed the deadline for. Due to a technical error we've given you til 30th May 23:59... so SUBMIT NOW: tinyurl.com/25cxh4bv

Raafiah Mussa (@raafiahmussa) 's Twitter Profile Photo

Thank you to the organisers of #ESOC2025 in Helsinki! 🇫🇮 Grateful for the opportunity to present my research and connect with collaborators and friends from around the world. European Stroke Org UCL Stroke Research UCL Queen Square Institute of Neurology #StrokeResearch #VoiceofStroke

Thank you to the organisers of #ESOC2025 in Helsinki! 🇫🇮

Grateful for the opportunity to present my research and connect with collaborators and friends from around the world.

<a href="/ESOstroke/">European Stroke Org</a> <a href="/UCLStrokeRes/">UCL Stroke Research</a> <a href="/UCLIoN/">UCL Queen Square Institute of Neurology</a> 
#StrokeResearch #VoiceofStroke
UCL Stroke Research (@uclstrokeres) 's Twitter Profile Photo

Extended CT angiography vs standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): prospective, randomised, open-label, blinded end-point trial - The Lancet Neurology thelancet.com/journals/laneu…

World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#MondayTip The stroke pathway and #ESOC2025 result Last week, Helsinki brought together the world’s leading stroke experts—leaving us with new evidence, fresh questions, and future challenges. All with one goal: improving outcomes for our patients European Stroke Org

#MondayTip

The stroke pathway and #ESOC2025 result

Last week, Helsinki brought together the world’s leading stroke experts—leaving us with new evidence, fresh questions, and future challenges. 

All with one goal: improving outcomes for our patients

<a href="/ESOstroke/">European Stroke Org</a>